Elacestrant (RAD1901) for Metastatic ER+ Advanced Breast Cancer
Aditya Bardia, MD, MPH of Harvard Medical School and Massachusetts General Hospital Cancer Center gives an overview of his presentation, Evaluation of RAD1901, a novel investigational, selective estro...
Author: ASCO2017
Added: 06/12/2017 (Source: Oncology Tube)
Source: Oncology Tube - June 12, 2017 Category: Cancer & Oncology Source Type: podcasts
Can RAD1901 Be Used in Breast Cancer Patients with ESR1 Mutations?
Aditya Bardia, MD, MPH of Harvard Medical School and Massachusetts General Hospital Cancer Center discusses common questions he's asked regarding his study on the use of elacestrant (RAD1901) for ER+ ...
Author: ASCO2017
Added: 06/12/2017 (Source: Oncology Tube)
Source: Oncology Tube - June 12, 2017 Category: Cancer & Oncology Source Type: podcasts
How to build a resillient health system
The 2014 west African Ebola epidemic shone a harsh light on the health systems of Guinea, Liberia, and Sierra Leone. While decades of domestic and international investment had contributed to substantial progress on the Millennium Development Goals, national health systems remained weak and were unable to cope with the epidemic.
Margaret Kruk associate professor of global health at the Harvard TH Chan School of Public Health, joins us to discuss what makes a health system resilient, and how Liberia in particular has learned lessons from Ebola.
Read the full analysis:http://www.bmj.com/content/357/bmj.j2323 (Source: The BMJ Podcast)
Source: The BMJ Podcast - June 8, 2017 Category: General Medicine Authors: BMJ talk medicine Source Type: podcasts
How to build a resillient health system
The 2014 west African Ebola epidemic shone a harsh light on the health systems of Guinea, Liberia, and Sierra Leone. While decades of domestic and international investment had contributed to substantial progress on the Millennium Development Goals, national health systems remained weak and were unable to cope with the epidemic.
Margaret Kruk associate professor of global health at the Harvard TH Chan School of Public Health, joins us to discuss what makes a health system resilient, and how Liberia in particular has learned lessons from Ebola.
Read the full analysis:
http://www.bmj.com/content/357/bmj.j2323 (Source: The BMJ Podcast)
Source: The BMJ Podcast - June 8, 2017 Category: General Medicine Authors: BMJ Group Source Type: podcasts
Define Optimal 2nd Line Treatment and Sequence: Subgroup Analysis from Pivotal Studies and Real World Data
David McDermott, MD of the Dana-Farber/Harvard Cancer Center outlines and Defines Optimal 2nd Line Treatment and Sequence: Subgroup Analysis from Pivotal Studies and Real World Data at the 12th Euro...
Author: kidneycancer
Added: 04/25/2017 (Source: Oncology Tube)
Source: Oncology Tube - April 25, 2017 Category: Cancer & Oncology Source Type: podcasts
Telotristat and Somatostatin Analogue in Advanced Neuroendocrine Tumors
Matthew H. Kulke, MD, MMSc of Dana-Farber and Harvard Medical School explains whether or not somatostatin analogues were needed to see efficacy in treatment for carcinoid syndromes. This was recorded ...
Author: NCCN2017
Added: 03/31/2017 (Source: Oncology Tube)
Source: Oncology Tube - March 31, 2017 Category: Cancer & Oncology Source Type: podcasts
TELESTAR Results and Telotristat Ethyl for Advanced Neuroendocrine Tumors
Matthew H. Kulke, MD, MMSc of Dana-Farber and Harvard Medical School gives an overview of his discussion, Novel Treatment Options for Neuroendocrine Tumors, which was presented at the 2017 National Co...
Author: NCCN2017
Added: 03/31/2017 (Source: Oncology Tube)
Source: Oncology Tube - March 31, 2017 Category: Cancer & Oncology Source Type: podcasts
NETTER-1 and Octreotide for Advanced Small Bowel Carcinoids
Matthew H. Kulke, MD, MMSc of Dana-Farber and Harvard Medical School discusses the results of the NETTER-1 study, which concluded with patients who were treated with octreotide had significantly impro...
Author: NCCN2017
Added: 03/31/2017 (Source: Oncology Tube)
Source: Oncology Tube - March 31, 2017 Category: Cancer & Oncology Source Type: podcasts
American healthcare - what next?
For seven years, Republicans have vowed to repeal the Affordable Healthcare Act (Obamacare), and that promise took a central place in President Trump's campaign. The first major vote to replace it was due to happen last week, but was cancelled at the 11th hour.
In advance of the potential vote, The BMJ published a debate asking "Should US doctors mourn for Obamacare?". Now we're asking the authors of that debate, what next?
Joining Peter Doshi are Adam Gaffney, from Harvard Medical School and Saurabh Jha from the Hospital of the University of Pennsylvan ia.
Read their original debate:http://www.bmj.com/content/356/bmj....
Source: The BMJ Podcast - March 29, 2017 Category: General Medicine Authors: BMJ talk medicine Source Type: podcasts
American healthcare - what next?
For seven years, Republicans have vowed to repeal the Affordable Healthcare Act (Obamacare), and that promise took a central place in President Trump's campaign. The first major vote to replace it was due to happen last week, but was cancelled at the 11th hour.
In advance of the potential vote, The BMJ published a debate asking "Should US doctors mourn for Obamacare?". Now we're asking the authors of that debate, what next?
Joining Peter Doshi are Adam Gaffney, from Harvard Medical School and Saurabh Jha from the Hospital of the University of Pennsylvania.
Read their original debate:
http://www.bmj.com/content/356/bmj.j...
Source: The BMJ Podcast - March 29, 2017 Category: General Medicine Authors: BMJ Group Source Type: podcasts
Episode 38: Chew on This
Reintegrating dental and medical care (Source: Harvard Medical Labcast)
Source: Harvard Medical Labcast - February 24, 2017 Category: Biomedical Science Authors: Harvard Medical School Office of Communications and External Relations Source Type: podcasts
Alzheimer Outlook Far From Bleak
Rudolph Tanzi, PhD, of Harvard University, and Berislav Zlokovic, MD, PhD, of the University of Southern California, discuss what the future holds for Alzheimer Disease research and treatment. (Source: JAMA Author Interviews)
Source: JAMA Author Interviews - February 15, 2017 Category: Journals (General) Authors: JAMA, the Journal of the American Medical Association, and The JAMA Network Source Type: podcasts
ASFH The Glaucoma Contact Lens -- part 2
Guests: Joseph B. Ciolino, MD Henry Freeman Allen Cornea Scholar Schepens Eye Research Institute Harvard Medical School Massachusetts Eye and Ear Infirmary Boston, MA Daniel S. Kohane MD, PhD. Professor of Anesthesia Harvard Medical School Boston, MA (Source: As Seen From Here)
Source: As Seen From Here - January 1, 2017 Category: Opthalmology Authors: JYoungMD at gmail.com Source Type: podcasts
ASFH The Glaucoma Contact Lens -- part 1
Guests: Joseph B. Ciolino, MD Henry Freeman Allen Cornea Scholar Schepens Eye Research Institute Harvard Medical School Massachusetts Eye and Ear Infirmary Boston, MA Daniel S. Kohane MD, PhD. Professor of Anesthesia Harvard Medical School Boston, MA (Source: As Seen From Here)
Source: As Seen From Here - December 19, 2016 Category: Opthalmology Authors: JYoungMD at gmail.com Source Type: podcasts
